Fluorescent Ureteral Catheter-Assisted Retroperitoneoscopic Biopsy for Periureteral IgG4-Related Disease Mimicking Upper Tract Urothelial Carcinoma. [PDF]
IJU Case RepABSTRACT Introduction Periureteral IgG4‐related disease (IgG4‐RD) is rare and can mimic upper tract urothelial carcinoma (UTUC), sometimes leading to unnecessary nephroureterectomy. Diagnosis is challenging when endoscopic biopsy is inconclusive and percutaneous biopsy is unsafe.
Yoshida T +9 more
europepmc +2 more sources
Diagnostic ureteroscopy in CT urography-diagnosed upper tract urothelial carcinoma: delay in definitive treatment and increased intravesical recurrence [PDF]
, 2021 Purpose To investigate the effect of diagnostic ureteroscopy (URS) on the delay to surgical treatment of upper tract urothelial carcinoma (UTUC) detected by imaging and the risk of intravesical recurrence.
Shsm, Hadi +4 more
core +1 more source
Surgical management for upper urinary tract transitional cell carcinoma [PDF]
, 2011 Background Upper tract transitional cell carcinomas (TCC) are uncommon and aggressive tumours. There are a number of surgical approaches to manage this condition including open radical nephroureterectomy and laparoscopic procedures.
El-Mokadem, Ismail +11 more
core +1 more source
Use of the T-1470 LiteTouch™ Laser in the En Bloc Resection of an Upper Tract Urothelial Cancer
Case Reports in Urology, 2021 Background. Endoscopic laser-ablative therapy of upper tract urothelial carcinoma offers kidney-sparing treatment for well-selected low-risk tumors. The traditional technique consists of tumor biopsy with flexible forceps or nitinol basket for pathologic
Ezra Shoen +4 more
doaj +1 more source
Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification [PDF]
Journal of Nephropathology, 2023 The incidence of urothelial carcinoma is increasing worldwide (including in Iran). Bladder cancer can be classified in various manners according to the standardized histomorphology set by the World Health Organization (WHO). Various genetic modifications
Fateme Khalatbari +2 more
doaj +1 more source
[Instillation therapies for urothelial carcinoma of the upper urinary tract]. [PDF]
, 2019 Traditionally, urothelial carcinoma of the upper urinary tract was a clear indication for radical nephroureterectomy with bladder cuff excision. It has been shown that in well-selected patients and depending on tumor stage, a kidney-sparing approach can ...
Roth, Beat +2 more
core +1 more source
Urology Case Reports, 2017 Port Site Recurrence (PSR) following laparoscopic tumor resections has been reported for a variety of tumors. Though PSR is a rare phenomenon, they most commonly occur following nephroureterectomies for upper tract urothelial carcinoma.
Jonathan Elliott Katz +3 more
doaj +1 more source
"The creeping tumor:" An unusual presentation of upper urinary tract malignancy
Indian Journal of Urology, 2014 Upper urinary tract urothelial malignancy accounts for 5-10% of urothelial carcinomas. Synchronous bladder carcinoma occurs in 2-4% of patients with upper urinary tract tumors.
Velaiyan Selvaraj +3 more
doaj +1 more source
CT Urography Findings of Upper Urinary Tract Carcinoma and Its Mimickers: A Pictorial Review
Medicina, 2020 Urothelial carcinoma (UC) is the fourth most frequent tumor in Western countries and upper tract urothelial carcinoma (UTUC), affecting pyelocaliceal cavities and ureter, accounts for 5–10% of all UCs.
Paola Martingano +4 more
doaj +1 more source
A review of the contemporary management of upper urinary tract urothelial carcinoma
, 2017 Upper tract urothelial carcinoma (UTUC) is relatively rare and accounts for approximately 5% of all urothelial carcinomas. The estimated annual incidence of UTUC in Western countries is about two new cases per 100,000 inhabitants.
Seshadri Sriprasad +2 more
core +2 more sources